Cancer as chronic disease--new focus treatment

Options
wallycat
wallycat Member Posts: 3,227
edited August 2016 in Clinical Trials, Research News, Podcasts, and Study Results

https://www.sciencedaily.com/releases/2016/08/1608...

· Share on FacebookShare on Twitter

Comments

  • JohnSmith
    JohnSmith Member Posts: 651
    edited August 2016

    This is an interesting idea since it opens up the possibility of using numerous agents together. Each agent aimed at a specific cancer pathway. The more pathways that are blocked, the better chance of a curative effect. Since side effects (toxicity) is the number one problem with a multi-agent approach, using metronomic dosage regimen and lower doses of each drug may be wise idea.

    I believe some researchers suggest this metronomic dosage approach might be useful for PI3K inhibitors, which tend to generate numerous side effects, which was discussed in this thread: ER+ Cancer and drug resistance.

    · Share on FacebookShare on Twitter
  • wallycat
    wallycat Member Posts: 3,227
    edited August 2016

    And one of the meds in the article is actually associated with extended longevity in "normal" people.

    Everything helps! I know Gleevic is a maintenance program as well, not a cure. Would be amazing to think of cancer in the same mind-frame as obesity and heart disease rather than immanent death.


    · Share on FacebookShare on Twitter

Categories